Back to Search
Start Over
Imatinib mesylate can induce complete molecular remission in FIP1L1-PDGFR-a positive idiopathic hypereosinophilic syndrome.
- Source :
-
Haematologica [Haematologica] 2004 Feb; Vol. 89 (2), pp. 236-7. - Publication Year :
- 2004
- Subjects :
- Aged
Benzamides
Enzyme Inhibitors pharmacology
Exons genetics
HL-60 Cells
Humans
Hypereosinophilic Syndrome genetics
Imatinib Mesylate
Male
Oncogene Proteins, Fusion genetics
Piperazines pharmacology
Pyrimidines pharmacology
RNA Splicing
RNA, Messenger genetics
Remission Induction
Enzyme Inhibitors therapeutic use
Hypereosinophilic Syndrome drug therapy
Oncogene Proteins, Fusion antagonists & inhibitors
Piperazines therapeutic use
Pyrimidines therapeutic use
Receptor, Platelet-Derived Growth Factor alpha antagonists & inhibitors
Receptor, Platelet-Derived Growth Factor alpha genetics
mRNA Cleavage and Polyadenylation Factors antagonists & inhibitors
mRNA Cleavage and Polyadenylation Factors genetics
Subjects
Details
- Language :
- English
- ISSN :
- 1592-8721
- Volume :
- 89
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Haematologica
- Publication Type :
- Academic Journal
- Accession number :
- 15003901